We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
US pharma Pacira hopes for a further expansion of the label for its nerve block Exparel covering surgical procedures throughout the body, after the FDA opted to expand its use to include shoulder surgery late last week.